SCHEMBL6510069

SCHEMBL6510069

COC(=O)C(CC(C)C)N(C)c1nc(Nc2cccc(F)c2)cc(Sc2ccc(OC)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PTGIR P43119 1/20 0.35
MAPT P10636 3/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
POLB P06746 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
AURKB Q96GD4 1/20 0.34
RECQL P46063 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510073 1.00 HPGD (0.39) HPGDL3MBTL1ALDH1A1CYP1A2CYP2D6
SCHEMBL6508234 0.93 HPGD (0.37) HPGDL3MBTL1ALDH1A1CYP1A2CYP2D6
SCHEMBL6514102 0.93 HPGD (0.40) HPGDL3MBTL1ALDH1A1MAPTTP53
SCHEMBL6512117 0.83 CTSK (0.38) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6512111 0.83 CTSK (0.38) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513221 0.82 CTSK (0.40) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6513215 0.82 CTSK (0.40) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6510461 0.80 ALDH1A1 (0.40) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6510466 0.80 ALDH1A1 (0.40) L3MBTL1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6509288 0.80 ATM (0.35) L3MBTL1ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed